Table 1.
Summary table of the evidence for NF-κB involvement in response to CO2
Experimental model | Cellular Effect | Evidence of NF-κB involvement | Reference |
---|---|---|---|
Rat hepatic IRI | ↓ TNFα | ↓ NF-κB staining by IHC | Li et al. |
↑ IL-10 | |||
↓ Apoptosis | |||
↓ Liver injury | |||
In vitro buffered hypercapnia (MEF, A549 lung epithelial cells and others) | ↓ TNFα, ICAM-1 and CCL2 | ↓ NF-κB luciferase promoter reporter | Cummins et al. |
↑ IL-10 | ↓ Nuclear p65 accumulation | ||
↓ IκBα degradation | |||
↑ Nuclear lKKα | |||
In vitro hypercapnic acidosis (pulmonary endothelial cells) | ↓ ICAM-1, IL-8 | ↓ Nuclear p65 binding (EMSA) | Takeshita et al. |
↓ Neutrophil adherence | ↓ IκBα degradation | ||
In vitro hypercapnia (macrophages) | ↓ IL-6, TNFα | No change in p65 or IκBα | Wang et al. |
IL-10 unaffected | ↓ IL-6 promoter activity | ||
↓ Phagocytosis | |||
In vitro hypercapnia acidosis (wound healing model in A549 lung epithelial cells) | ↓ Wound healing | ↓ IκBα degradation | O’Toole et al. |
↓ Cell migration | ↓ NF-κB luciferase promoter reporter | ||
Effect of HCA lost when NF-κB inhibited | |||
Drosophila (flies +/− pathogen at a range of CO2 concentrations) | ↑ Mortality | Proteolytic cleavage of Relish unchanged | Helenius et al. |
↓ Antimicrobial peptide genes | Hypercapnia inhibits Rel targets in parallel or downstream of proteolytic activation of Rel |